Concizumab May Be Effective Prophylaxis for Hemophilia A or B With Inhibitors

FRIDAY, Sept. 1, 2023 -- Patients with hemophilia A or B with inhibitors have a lower annualized bleeding rate with concizumab than with no prophylaxis, according to a phase 3 study published online Aug. 31 in the New England Journal of...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news